A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.
It is almost impossible for an injured heart to fully mend itself. Within minutes of being deprived of oxygen – as happens during a heart attack when arteries to the heart are blocked – the heart’s muscle cells start to die. Sanjay Sinha wants to mend these hearts so that they work again.
Transparency without accessibility is not enough: stats must be put in context, say researchers.
Some people with high levels of ‘good’ high density lipoprotein cholesterol (HDL-C) are at increased risk of coronary heart disease, contrary to earlier evidence that people with more HDL-C are usually at lower heart disease risk. This finding comes from an international study involving researchers at the University of Cambridge, funded by the British Heart Foundation (BHF).
“Listen to your heart,” sang Swedish pop group Roxette in the late Eighties. But not everyone is able to tune into their heartbeat, according to an international team of researchers – and half of us under- or over-estimate our ability.
Scientists led by the University of Cambridge and the Medical Research Council (MRC) have developed a new drug that could help reduce the tissue damage that occurs following a heart attack, stroke or major surgery.
Research paves the way for new approaches in the treatment of pulmonary arterial hypertension, a progressive lung disease that can lead to heart failure within three years.